Literature DB >> 2477429

Observations on the pathogenesis of nasal priming.

M Wachs1, D Proud, L M Lichtenstein, A Kagey-Sobotka, P S Norman, R M Naclerio.   

Abstract

To understand better the response of patients with allergic rhinitis to nasal challenge with antigen, we studied the mechanism of priming, that is, the increased clinical response to daily sequential nasal challenges. Ten subjects with ragweed hay fever were challenged four times with increasing doses of ragweed pollen. The first 2 challenge days were separated by 2 weeks, whereas the last three challenges occurred on sequential days. Nasal lavages, performed before and after each nasal challenge, were evaluated for levels of inflammatory mediators and cellular content. In contrast to control days, a significant (p less than 0.05) increase in the number of sneezes occurred on both priming days. Priming was associated with a significant increase in the level of histamine on both priming days, whereas the second priming day was also associated with an increase in TAME-esterase activity, kinins, and prostaglandin D2 obtained after challenge (p less than 0.05 for all). In the lavages before challenge on the priming days, the total number of cells and the number of neutrophils, eosinophils, and alcian blue-positive cells were significantly increased, but in contrast, basal levels of mediators were not. The net increase in the number of alcian blue-positive cells correlated with the net increase in the amount of histamine released on the priming days (r = 0.661; p less than 0.05). These studies suggest that priming results, in part, from increased mediator release from influxing inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477429     DOI: 10.1016/0091-6749(89)90362-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  11 in total

Review 1.  Clinical practice. Allergic rhinitis.

Authors:  Lisa M Wheatley; Alkis Togias
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

2.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

3.  Pathophysiology of nasal congestion.

Authors:  Robert M Naclerio; Claus Bachert; James N Baraniuk
Journal:  Int J Gen Med       Date:  2010-04-08

Review 4.  Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies.

Authors:  G W Canonica; E Compalati
Journal:  Clin Exp Immunol       Date:  2009-08-25       Impact factor: 4.330

5.  Concentrations of chemical mediators in nasal secretions after nasal allergen challenges in atopic patients.

Authors:  D Wang; P Clement; J Smitz; M P Derde
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

6.  Mast cells, eosinophils and IgE-positive cells in the nasal mucosa of patients with vasomotor rhinitis. An immunohistochemical study.

Authors:  H M Blom; T Godthelp; W J Fokkens; A Klein Jan; A F Holm; T M Vroom; E Rijntjes
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

7.  Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma.

Authors:  Marie-Claire Rousseau; Marie-Eve Boulay; Loie Goronfolah; Judah Denburg; Paul Keith; Louis-Philippe Boulet
Journal:  Allergy Asthma Clin Immunol       Date:  2011-04-20       Impact factor: 3.406

8.  Difference in symptom severity between early and late grass pollen season in patients with seasonal allergic rhinitis.

Authors:  Letty A de Weger; Thijs Beerthuizen; Jeannette M Gast-Strookman; Dirk T van der Plas; Ingrid Terreehorst; Pieter S Hiemstra; Jacob K Sont
Journal:  Clin Transl Allergy       Date:  2011-12-21       Impact factor: 5.871

Review 9.  Risk multipliers for severe food anaphylaxis.

Authors:  Peter K Smith; Jonathan O'B Hourihane; Phil Lieberman
Journal:  World Allergy Organ J       Date:  2015-11-24       Impact factor: 4.084

Review 10.  Objective monitoring of nasal patency and nasal physiology in rhinitis.

Authors:  Robert A Nathan; Ron Eccles; Peter H Howarth; Sverre K Steinsvåg; Alkis Togias
Journal:  J Allergy Clin Immunol       Date:  2005-03       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.